ARTICLE | Company News
Avanir, Novartis neurology news
September 2, 2013 7:00 AM UTC
Avanir and Novartis' Sandoz generics division settled a May suit alleging Sandoz's ANDA for a generic version of Nuedexta dextromethorphan/quinidine to treat pseudobulbar affect (PBA) infringes Avani...